Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by wyndeweston Jul 10, 2017 11:34am
279 Views
Post# 26450899

RE:RE:RE:RE:RE:Email from Pierre Laurin

RE:RE:RE:RE:RE:Email from Pierre LaurinSah1 & Felco, I like your posts but unfortunately it is out of Pierre's hands to surprise us with somethingto the upside.  For now it is up to the FDA to do this.... so we wait, with no idea how long the wait will be.  What really annoys me is, I think Prometic paid a fee to the FDA to be considered for BLA Priority review (and pediatric voucher).  So we paid $ to the FDA to be told ,after the fact, that they are behind schedule but have put a plan in place to try and catch up. I sure hope their plan works.
Bullboard Posts